203 related items for PubMed ID: 9010713
1. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
Horm Res; 1997; 47(1):17-22. PubMed ID: 9010713
[Abstract] [Full Text] [Related]
2. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
Aycan Z, Ocal G, Berberoglu M, Cetinkaya E, Adiyaman P, Evliyaoglu O.
J Pediatr Endocrinol Metab; 2006 Mar; 19(3):245-51. PubMed ID: 16607925
[Abstract] [Full Text] [Related]
3. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W, Schwarz HP.
Horm Res Paediatr; 2011 Mar; 75(4):264-8. PubMed ID: 21196707
[Abstract] [Full Text] [Related]
4. Auxological and biochemical parameters in assessing treatment of infants and toddlers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Einaudi S, Lala R, Corrias A, Matarazzo P, Pagliardini S, de Sanctis C.
J Pediatr Endocrinol; 1993 Mar; 6(2):173-8. PubMed ID: 8348221
[Abstract] [Full Text] [Related]
5. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Völkl TM, Simm D, Beier C, Dörr HG.
Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
[Abstract] [Full Text] [Related]
6. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W, Schmidt H, Schwarz HP.
Horm Res Paediatr; 2011 Jan; 75(1):32-7. PubMed ID: 20714115
[Abstract] [Full Text] [Related]
7. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
Muirhead S, Sellers EA, Guyda H, Canadian Pediatric Endocrine Group.
J Pediatr; 2002 Aug; 141(2):247-52. PubMed ID: 12183722
[Abstract] [Full Text] [Related]
8. Adult height in women with early-treated congenital adrenal hyperplasia (21-hydroxylase type): relation to body mass index in earlier childhood.
Yu AC, Grant DB.
Acta Paediatr; 1995 Aug; 84(8):899-903. PubMed ID: 7488814
[Abstract] [Full Text] [Related]
9. Patients with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency can achieve their target height: the Leipzig experience.
Hoepffner W, Kaufhold A, Willgerodt H, Keller E.
Horm Res; 2008 Aug; 70(1):42-50. PubMed ID: 18493149
[Abstract] [Full Text] [Related]
10. Aromatase Inhibitor as Treatment for Severely Advanced Bone Age in Congenital Adrenal Hyperplasia: A Case Report.
Goedegebuure WJ, Hokken-Koelega ACS.
Horm Res Paediatr; 2019 Aug; 92(3):209-213. PubMed ID: 31390647
[Abstract] [Full Text] [Related]
11. Failure of cortisone acetate therapy in 21-hydroxylase deficiency in early infancy.
Jinno K, Sakura N, Nomura S, Fujitaka M, Ueda K, Kihara M.
Pediatr Int; 2001 Oct; 43(5):478-82. PubMed ID: 11737708
[Abstract] [Full Text] [Related]
12. Compensatory maturational deceleration of growth or "catch-down growth" in patients with congenital adrenal hyperplasia after delayed initiation of therapy.
Hunziker U, Largo R, Zachmann M, Prader A.
Eur J Pediatr; 1986 Apr; 144(6):550-3. PubMed ID: 3486767
[Abstract] [Full Text] [Related]
13. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
Van der Kamp HJ, Otten BJ, Buitenweg N, De Muinck Keizer-Schrama SM, Oostdijk W, Jansen M, Delemarre-de Waal HA, Vulsma T, Wit JM.
Arch Dis Child; 2002 Aug; 87(2):139-44. PubMed ID: 12138066
[Abstract] [Full Text] [Related]
14. [Comparative study of prednisolone versus hydrocortisone acetate for treatment of patients with the classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
Leite FM, Longui CA, Kochi C, Faria CD, Borghi M, Calliari LE, Monte O.
Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):101-8. PubMed ID: 18345402
[Abstract] [Full Text] [Related]
15. 17-Hydroxyprogesterone rhythms and growth velocity in congenital adrenal hyperplasia.
Pincus DR, Kelnar CJ, Wallace AM.
J Paediatr Child Health; 1993 Aug; 29(4):302-4. PubMed ID: 8373678
[Abstract] [Full Text] [Related]
16. Characteristics of Growth in Children With Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency During Adrenarche and Beyond.
Troger T, Sommer G, Lang-Muritano M, Konrad D, Kuhlmann B, Zumsteg U, Flück CE.
J Clin Endocrinol Metab; 2022 Jan 18; 107(2):e487-e499. PubMed ID: 34599587
[Abstract] [Full Text] [Related]
17. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
Clin Endocrinol (Oxf); 2002 Nov 18; 57(5):669-76. PubMed ID: 12390343
[Abstract] [Full Text] [Related]
18. [Growth and adult height in patients with congenital adrenal hyperplasia].
Kolousková S, Zemková D, Snajderová M, Lebl J.
Cas Lek Cesk; 1995 Nov 01; 134(21):689-91. PubMed ID: 8556761
[Abstract] [Full Text] [Related]
19. Growth in disorders of adrenal hyperfunction.
Savage MO, Scommegna S, Carroll PV, Ho JT, Monson JP, Besser GM, Grossman AB.
Horm Res; 2002 Nov 01; 58 Suppl 1():39-43. PubMed ID: 12373013
[Abstract] [Full Text] [Related]
20. Blood pressure in the first year of life in children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a pilot study.
Mooij CF, Kapusta L, Otten BJ, Claahsen-van der Grinten HL.
Horm Res Paediatr; 2010 Nov 01; 74(5):328-32. PubMed ID: 20357427
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
